You've noticed your jaw looks wider in photos, especially when you clench. You're considering injections, but the search results leave you comparing brands, unit counts, and prices without answering the question that matters: will either treatment give you a slimmer lower face without changing how you chew or smile? For Dysport vs Botox for jawline slimming, the useful answer starts with your anatomy, not a preference for one vial.
Table of Contents
- Why Patients Ask This the Wrong Way
- How Neuromodulators Actually Slim the Jawline
- Side-by-Side Comparison of Botox and Dysport for the Jawline
- When You Will Actually See the Jawline Change
- Who Is a Good Candidate and Who Should Pause
- Risks, Spread, and the Real Cost Question
- Choosing the Right Option for Your Goals
- Booking a Jawline Consult at ProMD Health DC
Why Patients Ask This the Wrong Way
Consider a consultation where someone sits down wanting a narrower jaw and asks which brand works better. This is a hypothetical scenario, not a patient case, but it captures the decision clearly: the patient has already chosen the category of treatment before establishing what makes the jaw look broad.
An injector needs to work backward. Is the width coming from prominent masseter muscles? Does the patient clench? Is there existing lower-face laxity that could become more noticeable after muscle reduction? Would the patient accept a modest contour change if that better protects chewing comfort?
Those questions matter more than whether a friend preferred Dysport.
Start with the endpoint
A useful consultation separates goals that patients often combine:
- Facial narrowing: You want less width at the back of the lower face.
- Clenching concerns: You want to discuss muscle activity and its functional consequences.
- Preserving expression: You want a subtle change without compromising your familiar smile.
- Maintenance tolerance: You want a plan that fits how often you're comfortable returning.
These aren't interchangeable endpoints. Someone seeking contour improvement may judge success by photographs, while someone concerned about grinding may care more about symptoms and dental guidance.
The evidence doesn't establish a universal brand winner. A meta-analysis summarized in a masseter treatment guide included five randomized trials involving 536 participants, finding short-term aesthetic improvement but insufficient evidence to establish an optimal dose or protocol.
Practical rule: Choose a treatment plan you can understand before choosing a brand you recognize.
For a downtown DC consultation, the useful outcome isn't an appointment booked for injections. It's a documented assessment of what can reasonably change, what should remain untouched, and when treatment should be deferred. A responsible recommendation can be conservative treatment, further evaluation, or no masseter treatment at all.
How Neuromodulators Actually Slim the Jawline
The masseter is a chewing muscle along the side of the jaw. When muscle bulk contributes to a broad lower face, reducing its activity can gradually reduce that bulk. This is muscle-focused contouring, not a general solution for every source of jawline fullness.
Botox Cosmetic contains onabotulinumtoxinA. Dysport contains abobotulinumtoxinA. Both act at the neuromuscular junction by inhibiting acetylcholine release, reducing the signal that tells the treated muscle to contract. The important distinction for patients is that reduced activity and visible facial narrowing aren't the same event.

What the examination needs to establish
Before discussing a dose, the clinician should assess the muscle at rest and during clenching. Palpation helps establish where the muscle is prominent, whether the sides differ, and whether the fullness appears consistent with muscle rather than another structure.
The history matters just as much:
- Grinding and clenching: Describe when they occur and whether a dentist has assessed them.
- Jaw symptoms: Mention pain, restricted opening, or symptoms associated with the temporomandibular joint.
- Previous injections: Bring the product name, treatment date, dose, and response if available.
- Skin support: Discuss existing looseness and whether narrowing could make it more apparent.
The injector then considers the treatment map, depth, and distribution rather than treating the jaw as a single uniform target.
What off-label treatment means
Masseter contouring is off-label for both products in the United States. Neither has an FDA-approved masseter indication. That should be part of informed consent, not something patients discover after treatment.
Product units also require explanation. They represent product-specific biological potency, not a shared measurement that can be transferred unchanged between brands. The prescribing distinction becomes especially important when comparing treatment proposals.
A good consultation therefore ends with more than a unit count. You should understand which muscle is being treated, why that muscle fits your goal, and how the clinician intends to protect function while pursuing contour change.
Side-by-Side Comparison of Botox and Dysport for the Jawline
Botox vs Dysport for the jawline at a glance
| Criterion | Botox Cosmetic | Dysport |
|---|---|---|
| Active ingredient | OnabotulinumtoxinA | AbobotulinumtoxinA |
| Dose interpretation | Uses its own potency units | Uses its own potency units |
| Masseter dosing comparison | Must be planned specifically for this product | Must not substitute the same numerical unit count |
| Early response | Muscle effects shouldn't be confused with final narrowing | An early response doesn't establish a faster final contour result |
| Spread considerations | Placement and dose distribution matter | Placement and dose distribution matter |
| Durability | Depends on the treatment plan and individual response | Available evidence doesn't establish universal superiority |
| Practical selection | Consider prior response and injector familiarity | Consider prior response and injector familiarity |
Dose math isn't a strength ranking
A comparative masseter protocol used 75 Dysport units versus 30 Botox units per side, applying an approximate 2.5:1 convention, but product-specific prescribing guidance states that potency units aren't interchangeable.
That convention describes a clinical dosing approach. It isn't a regulatory conversion formula, a prescription for every patient, or proof that one product is stronger.
A proposal with a larger numerical Dysport dose can't be judged against a Botox proposal by counting units alone. Ask whether the plans address comparable muscle bulk, use an appropriate distribution, and pursue the same endpoint.
Onset, spread, and duration need separate questions
The evidence doesn't justify promising that a small difference in initial onset will produce a meaningfully better masseter result. Feeling less force while clenching is also different from seeing a narrower face.
For spread, the practical concern is unwanted effect outside the intended muscle. A brand-level claim such as “this one spreads more” is too crude to substitute for a discussion of placement, depth, and dose distribution.
In a randomized comparison of five toxin products, investigators used 250 total Dysport units versus 100 total Botox units; bite-force reduction was greatest at approximately 2–4 weeks and generally reversed by about 4 months, although more than half of participants retained improvement beyond 16 weeks, as summarized in this abobotulinumtoxinA evidence review. That review reports Dysport-associated bite-force reduction lasting up to 16 weeks, compared with about 12 weeks for some comparator groups.
Those findings concern measured muscle function, not a guarantee of how long a particular face will look slimmer. They support individualized planning, not a declaration that Dysport always lasts longer.
When You Will Actually See the Jawline Change
Don't use your first post-treatment photographs to decide whether the dose was enough. A muscle can become less active before its reduced bulk becomes visually apparent, and a cosmetic result needs a different assessment window from an early functional response.
The distinction is especially important if you're planning around a professional event. A gradually evolving contour change isn't something to evaluate by repeatedly checking the mirror immediately after treatment.

Read a timeline as a range, not a promise
The early milestones illustrated above shouldn't be interpreted as a guaranteed peak. The available masseter data support allowing longer for the full contour response.
In a study of 10 women receiving 90 abobotulinumtoxinA units per side, lower-third reductions were 3.94% at 2 weeks, 5.26% at 4 weeks, 11.99% at 12 weeks, and 5.47% at 24 weeks, with statistically significant reduction reported at 2 and 12 weeks, according to the reported abobotulinumtoxinA study findings and product-labeling reference.
That's a small study, not a forecast for your face. Its useful lesson is the shape of the response: gradual change, a later maximum, and some subsequent loss of effect.
An early touch-up shouldn't be used to hurry a contour result that hasn't had time to develop.
Reassess before adding
A reasonable discussion is to reassess around 8–12 weeks, with retreatment often considered near 3–4 months, consistent with the comparative evidence discussed earlier. Timing should remain individualized rather than becoming an automatic standing order.
At follow-up, compare photographs taken under similar conditions, review chewing comfort, and examine symmetry. If there's an unexpected functional change, contact the treating clinician rather than waiting for the planned cosmetic review.
The question isn't just whether you could look narrower. It's whether the response is balanced and whether further reduction would still serve your original goal.
Who Is a Good Candidate and Who Should Pause
A broad jaw isn't enough to establish candidacy. True masseter prominence needs to be distinguished from parotid-gland enlargement and other contributors to lower-face fullness before the injector chooses a treatment plan.
A candidate may have noticeable muscle bulk during clenching and want a measured reduction in width. A history of grinding can inform the assessment, but it doesn't by itself establish that cosmetic injections are the right response.
Published starting doses aren't personal prescriptions
A peer-reviewed review of cosmetic toxin use describes initial Botox doses of approximately 15–25 units per side for Caucasian women, 30–50 units per side for East Asian women, and roughly 10 additional units per side for men. The same review warns about jowling in patients with laxity, paradoxical bulging during chewing, smile asymmetry, and difficulty opening the mouth.
These demographic categories describe the published guidance. They shouldn't replace an examination or become a menu from which patients select their own dose.
Muscle size, asymmetry, functional history, and skin support still require individual assessment. A clinician should be able to explain why a proposed dose suits your anatomy rather than relying on your demographic category alone.
Reasons to pause
- Uncertain source of fullness: Suspected gland prominence deserves assessment before cosmetic treatment.
- Significant lower-face laxity: Reducing muscle volume may be an unfavorable trade-off if the surrounding tissue already lacks support.
- Active dental infection or unresolved dental problems: Seek appropriate dental evaluation before pursuing elective contouring.
- Pain or migraine as the main concern: Request a condition-specific assessment rather than assuming a cosmetic masseter appointment addresses the diagnosis.
If your main concern is under-chin fullness rather than width over the jaw muscle, the discussion should change. This guide to addressing a double chin without surgery can help you distinguish the question you're bringing to the consultation.
Being willing to decline treatment is part of sound aesthetic judgment. A narrower lower face isn't automatically a better-balanced one.
Risks, Spread, and the Real Cost Question
The masseter does useful work. Reducing its activity means accepting a functional trade-off, not just removing unwanted bulk.
The risks most relevant to a jawline consultation include chewing fatigue, an altered smile, asymmetry, and an unwanted contour change. A clinician should discuss these plainly, including what follow-up will involve if something feels or looks wrong.

Precision matters more than reassurance
A surgical-anatomy study identifies the deep masseter within about 2 cm of the mandibular border as a generally preferred safety zone and reports jawline soft-tissue sagging after rapid masseter reduction in approximately 0.2%–2.3% of patients. This is anatomical guidance for clinicians, not a universal injection template.
A 2025 report describing a distorted smile after masseter injections illustrates why patients should discuss expression changes before treatment. It doesn't establish that this outcome is inevitable or unique to either brand.
Broader botulinum toxin safety guidance includes bruising, pain, redness, headache, nausea, temporary weakness, and drooping; rare toxin spread can cause difficulty swallowing, breathing problems, generalized weakness, or slurred speech. Seek urgent medical care for serious swallowing, breathing, or speech symptoms.
Compare the complete treatment cycle
A low advertised unit price doesn't tell you what the plan costs or whether it's appropriate. The relevant comparison includes:
- Total treatment price: What product and planned treatment are included?
- Review arrangements: How will the clinic assess response and handle concerns?
- Maintenance decisions: What would prompt retreatment rather than observation?
- Additional charges: Are follow-up injections, if clinically appropriate, separately priced?
Use the practice's guide to Botox costs to prepare questions, then request an individualized estimate.
Value check: A cheaper appointment isn't better value if the proposed endpoint doesn't suit your face.
Compare the total cost of an appropriate result cycle, not just the sticker price attached to unlike units.
Choosing the Right Option for Your Goals
The right choice depends on what you're trying to preserve as well as what you want to change. A consultation should translate that preference into a plan the clinician can assess, document, and review.
| Your priority | What deserves the most attention |
|---|---|
| Clenching comes first | Symptom history, dental input, and functional goals |
| Facial slimming comes first | Source of width, desired degree of narrowing, and tissue support |
| Avoiding overtreatment | A restrained endpoint and a clear review plan |
| Improving a previous treatment | Prior records, response, unwanted effects, and timing |

Match the recommendation to the person
Clenching-first patients should explain what bothers them in daily life, not just point to a jawline photograph. Cosmetic improvement and symptom relief need separate measures of success, and neither should substitute for appropriate dental care.
For slimming-first patients, the useful request is a defined degree of narrowing that still looks proportionate. Bring a description of the change you want, but remain open to the possibility that the apparent width isn't mainly muscular.
First-time patients often benefit from a deliberately restrained goal. There's no need to pursue the greatest possible reduction just because injections can reduce activity.
For returning patients, records are more useful than a vague memory that a product “worked better.” Bring the previous product, dose, distribution if available, and photographs showing both the favorable result and any unwanted change.
Brand is secondary to the treatment plan. A familiar label can't compensate for an unsuitable endpoint.
Know when the goal is different
Some patients say “slimmer” when they mean “more defined” or “better projected.” Those requests shouldn't automatically lead to masseter reduction.
The distinction between reducing width and adding structural definition is worth understanding before comparing treatments. The practice's chin and jaw filler overview addresses that separate contouring conversation.
For Dysport vs Botox for jawline treatment, the strongest recommendation is the one that explains both what the proposed treatment can accomplish and what it won't address.
Booking a Jawline Consult at ProMD Health DC
Plan your visit to the Washington, DC office at 1003 K Street NW as an assessment, not a commitment to injections. Bring your medication and medical history, relevant dental information, and previous treatment records if you have them.
Useful photographs include your usual resting expression and any earlier images that help explain the change you've noticed. Tell the clinician about professional or personal commitments that make a change in chewing comfort or facial expression especially consequential.
Does Dysport spread more than Botox?
Don't use that claim as a shortcut for choosing a product. The clinically useful question is how the injector will control the intended treatment area and account for your anatomy. The evidence discussed above doesn't establish a universally safer or better masseter choice on spread alone.
What if I grind my teeth?
Tell the clinician whether a dentist has diagnosed grinding, whether you use an appliance, and what symptoms you experience. Don't assume a slimmer jaw proves that grinding has been adequately managed. Ask how cosmetic follow-up will remain distinct from dental evaluation.
When is a touch-up appropriate?
An additional injection should follow an examination and a clear clinical reason, not disappointment with an early selfie. The clinician should consider the existing response, function, and treatment record before deciding whether more product is appropriate. An unwanted effect is a reason for assessment, not an automatic reason to add toxin.
What should I ask before agreeing?
Ask what makes you a candidate, which endpoint the clinician recommends, and what would make them stop short of further narrowing. You should also know whom to contact with concerns and how your response will be documented.
A useful consultation leaves you able to explain the recommendation in your own words. If the explanation stops at brand preference or a special price, ask for the anatomical reasoning.
ProMD Health Washington, DC offers Botox and Dysport with consultation-based planning for jawline concerns related to masseter prominence. Visit ProMD Health Washington, DC to schedule a jawline consultation and discuss whether conservative muscle reduction fits your goals, anatomy, and functional priorities.
